3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Colorectal Neoplasms
47
Pancreatic Neoplasms
43
Neoplasm Metastasis
20
Carcinoma, Hepatocellular
20
Lung Neoplasms
15
Ovarian Neoplasms
14
Colonic Neoplasms
14
Rectal Neoplasms
12
Stomach Neoplasms
11
Prostatic Neoplasms
11
Melanoma
11
Cholangiocarcinoma
11
Carcinoma, Renal Cell
10
Breast Neoplasms
10
Sarcoma
8
Lymphoma, Non-Hodgkin
8
Glioma
8
Carcinoma, Non-Small-Cell Lung
8
Neuroblastoma
7
Hepatoblastoma
7
Esophageal Neoplasms
7
Barrett Esophagus
7
Anus Neoplasms
7
Wilms Tumor
6
Uterine Cervical Neoplasms
6
Medulloblastoma
6
Gastrointestinal Neoplasms
6
Ependymoma
6
Central Nervous System Neoplasms
6
Adenocarcinoma Of Esophagus
6
Interventions
Cyclophosphamide
4
pembrolizumab
3
Nivolumab
3
regorafenib
2
fludarabine
2
SS1(dsFv)PE38
2
Ipilimumab
2
Hyperthermic Intraperitoneal Chemotherapy
2
Doxorubicin
2
Decitabine
2
Cisplatin
2
tislelizumab
1
sodium thiosulfate
1
sargramostim
1
entinostat
1
durvalumab
1
cemiplimab
1
bemcentinib
1
avelumab
1
atezolizumab
1
alvocidib
1
alanosine
1
X-Rays
1
Tetrahydrouridine
1
Tamoxifen
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Specimen Handling
1
Referral and Consultation
1
Radiotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Mesothelioma, Malignant
×
Specimen Handling
×
Gastrointestinal
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled